If you don't know where you are going, you'll wind up somewhere else.
- Yogi Berra

Given the high cost of R&D and the long delays in bringing a product to market, winding up somewhere else is a very time-consuming and expensive proposition for manufacturers.

Although the therapeutic development process involves high stakes and great uncertainty, it need not be a gamble. Large, well-established companies can leverage internal research efforts by partnering with smaller emerging companies who may have an edge in the early life-cycle of novel therapeutic approaches. Emerging companies with limited financial resources can attain commercial viability by coordinating competing priorities, rationalizing resources, and prudently selecting candidates for development. Venture capitalists and companies in-licensing therapeutics can avoid setting unrealistic expectations and making faulty partnering decisions by carefully assessing candidate market potential and likelihood of success.

Let BioMedical Insights work with you to take the guesswork out of product development.

BioMedical Insights' Technology Assessment Services

Whether you represent an emerging company, established company, or investor, BioMedical Insights can help you formulate market-driven commercialization strategies with confidence.

BioMedical Insights works closely with business development personnel and investors to assess the commercial feasibility and value of new opportunities. We provide market intelligence to support new product planning and help companies prioritize research efforts. We help companies search for, screen, and evaluate new therapeutic areas, both for internal R&D and as targets for corporate partnerships.

With scientific and marketing expertise, the experience gained from the evaluation of dozens of technologies, and ready access to clinical thought leaders and the latest drug development information, BioMedical Insights is expert at helping its clients match the right technologies to the right markets.

Client engagements include those representing:

• Business development managers
• Licensing and acquisitions directors
• Marketing managers
• Venture capitalists/investment bankers